In this podcast:
You will hear a panel discussion moderated by Dr Annette Schmid, Takeda Pharmaceuticals from the 2020 IO360° Summit regarding innovations and novel approaches in IO imaging and assessing responses.
Panelists include:
- Gregory Goldmacher, MD, PhD, MBA, Merck
- S. Peter Eggleton, MD, FFPM, Merck KGaA
- Ron Korn, MD, PhD, Imaging Endpoints
- Matthew Silva, PhD, Invicro
To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.
